跳至主要内容
临床试验/NCT04359056
NCT04359056Unknown不适用

Integration of Clinical Pharmacy Along the Entire Care Pathway of Patients Implanted With a PICC-line

University Hospital, Toulouse2 个研究点 分布在 1 个国家目标入组 138 人开始时间: 2020年5月25日最近更新:
适应症

试验速览

阶段
不适用
入组人数
138
试验地点
2
主要终点
Assessment of the number of complications during the interventional phase.

研究概览

简要总结

Clinical pharmacy is a patient-centered discipline and improves significantly the safety of drug management. Regarding medications, clinical pharmacy is efficient. The investigator hypothesize that clinical pharmacy applied to medical devices could be as effective as in the medication field.

The main objective of this study is to assess the effectiveness of clinical pharmacy activities during entire care pathways of patients implanted with a PICC line, in preventing complications.

详细描述

This is a preliminary, before-after, monocentric and prospective study. The study will begin with an observational period and will be followed by an experimental intervention period. Sixty-nine adult patients in each period will be included. During the observational phase, no clinical pharmacy activities will be performed. During the interventional phase, clinical pharmacists will be active during the entire patients' care pathways.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Sequential
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient, age equal to or older than 18 years old
  • Patient capable of giving free and informed consent
  • Patient insured by the Social Security System
  • Patient living at home
  • Patient with a PICC line prescription
  • Patient whose discharge prescription should contain drugs and MDs
  • Patient for home discharge implanted with a PICC line
  • Patient reachable by phone

排除标准

  • Under aged patient, age under 18 years old
  • Uninsured patient by the Social Security System
  • Patient not living at home :
  • Institutionalized patient
  • Patient living in a home for elderly dependent persons
  • Nursing home resident
  • Home-hospitalized patient
  • Patient deprived of liberty by a judicial or administrative decision
  • Patient under guardianship, curatorship or safeguard of justice
  • Patient unreachable by phone
  • Pregnant or breastfeeding women

结局指标

主要结局

Assessment of the number of complications during the interventional phase.

时间窗: 3 months

Number of complications per patient and per month in each group. Number of complications per patient and per month in each group

次要结局

  • Number of consultations and rehospitalizations post-discharge.(3 months)
  • Conformity analysis of the PICC line logistic circuit(day 0)
  • Conformity analysis of hospital prescriptions issued in town.(day 0)
  • healthcare professionals satisfaction survey(3 months)
  • Conformity analysis of treatment indication.(day 0)
  • Direct hospital costs.(3 months)
  • Participants satisfaction survey(3 months)
  • Acceptance rate of pharmaceutical interventions (PI) during interventional phase and evaluation of PIs' criticality.(3 months)
  • Patient's Quality Of Life assessment(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验